Fulcrum Therapeutics
FULC
#6285
Rank
A$1.26 B
Marketcap
A$19.19
Share price
-7.25%
Change (1 day)
186.92%
Change (1 year)

EPS for Fulcrum Therapeutics (FULC)

EPS in 2025 (TTM): A-$1.84

According to Fulcrum Therapeutics's latest financial reports the company's current EPS (TTM) is A-$1.77. In 2024 the company made an earnings per share (EPS) of A-$0.30 an increase over its 2023 EPS that were of A-$2.37.

EPS history for Fulcrum Therapeutics from 2019 to 2025

Annual EPS

Year EPS Change
2025 (TTM)A-$1.84514.14%
2024A-$0.30-87.34%
2023A-$2.37-36.29%
2022A-$3.728.3%
2021A-$3.43-18.51%
2020A-$4.21-31.36%
2019A-$6.14

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
ORIC Pharmaceuticals
ORIC
A-$2.59 46.61%๐Ÿ‡บ๐Ÿ‡ธ USA